169 related articles for article (PubMed ID: 29222744)
1. Activation of intestinal GR-FXR and PPARα-UGT signaling exacerbates ibuprofen-induced enteropathy in mice.
Lu Z; Lu Y; Wang X; Wang F; Zhang Y
Arch Toxicol; 2018 Mar; 92(3):1249-1265. PubMed ID: 29222744
[TBL] [Abstract][Full Text] [Related]
2. PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis.
Zhou X; Cao L; Jiang C; Xie Y; Cheng X; Krausz KW; Qi Y; Sun L; Shah YM; Gonzalez FJ; Wang G; Hao H
Nat Commun; 2014 Sep; 5():4573. PubMed ID: 25183423
[TBL] [Abstract][Full Text] [Related]
3. Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.
Yoshikawa K; Kurihara C; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Sato H; Narimatsu K; Okada Y; Higashiyama M; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Tajiri H; Hokari R
J Gastroenterol; 2017 Jan; 52(1):61-71. PubMed ID: 27075753
[TBL] [Abstract][Full Text] [Related]
4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
5. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
6. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia-Reperfusion Injury.
Wang X; Li S; Chen M; Liu J; Dong R; Wang H; Zhu S
Shock; 2018 Sep; 50(3):316-323. PubMed ID: 29028769
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.
Sayin SI; Wahlström A; Felin J; Jäntti S; Marschall HU; Bamberg K; Angelin B; Hyötyläinen T; Orešič M; Bäckhed F
Cell Metab; 2013 Feb; 17(2):225-35. PubMed ID: 23395169
[TBL] [Abstract][Full Text] [Related]
9. Lipid-activated transcription factors control bile acid glucuronidation.
Barbier O; Trottier J; Kaeding J; Caron P; Verreault M
Mol Cell Biochem; 2009 Jun; 326(1-2):3-8. PubMed ID: 19130183
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.
Zhong ZY; Sun BB; Shu N; Xie QS; Tang XG; Ling ZL; Wang F; Zhao KJ; Xu P; Zhang M; Li Y; Chen Y; Liu L; Xia LZ; Liu XD
Acta Pharmacol Sin; 2016 Jul; 37(7):1002-12. PubMed ID: 27180979
[TBL] [Abstract][Full Text] [Related]
11. NSAID acyl glucuronides and enteropathy.
Boelsterli UA; Ramirez-Alcantara V
Curr Drug Metab; 2011 Mar; 12(3):245-52. PubMed ID: 21395536
[TBL] [Abstract][Full Text] [Related]
12. Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk.
Al-Aqil FA; Monte MJ; Peleteiro-Vigil A; Briz O; Rosales R; González R; Aranda CJ; Ocón B; Uriarte I; de Medina FS; Martinez-Augustín O; Avila MA; Marín JJG; Romero MR
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2927-2937. PubMed ID: 29883717
[TBL] [Abstract][Full Text] [Related]
13. The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism.
Eloranta JJ; Jung D; Kullak-Ublick GA
Mol Endocrinol; 2006 Jan; 20(1):65-79. PubMed ID: 16123152
[TBL] [Abstract][Full Text] [Related]
14. Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.
Lukovac S; Los EL; Stellaard F; Rings EH; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G520-31. PubMed ID: 19608735
[TBL] [Abstract][Full Text] [Related]
15. Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury.
Zahiri HR; Perrone EE; Strauch ED
Surgery; 2011 Sep; 150(3):480-9. PubMed ID: 21878234
[TBL] [Abstract][Full Text] [Related]
16. FFA3 Activation Stimulates Duodenal Bicarbonate Secretion and Prevents NSAID-Induced Enteropathy via the GLP-2 Pathway in Rats.
Said H; Akiba Y; Narimatsu K; Maruta K; Kuri A; Iwamoto KI; Kuwahara A; Kaunitz JD
Dig Dis Sci; 2017 Aug; 62(8):1944-1952. PubMed ID: 28523577
[TBL] [Abstract][Full Text] [Related]
17. NSAID enteropathy and bacteria: a complicated relationship.
Syer SD; Blackler RW; Martin R; de Palma G; Rossi L; Verdu E; Bercik P; Surette MG; Aucouturier A; Langella P; Wallace JL
J Gastroenterol; 2015 Apr; 50(4):387-93. PubMed ID: 25572030
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation.
Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A
Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383
[TBL] [Abstract][Full Text] [Related]
19. An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.
Xie C; Jiang C; Shi J; Gao X; Sun D; Sun L; Wang T; Takahashi S; Anitha M; Krausz KW; Patterson AD; Gonzalez FJ
Diabetes; 2017 Mar; 66(3):613-626. PubMed ID: 28223344
[TBL] [Abstract][Full Text] [Related]
20. FXR Regulates Intestinal Cancer Stem Cell Proliferation.
Fu T; Coulter S; Yoshihara E; Oh TG; Fang S; Cayabyab F; Zhu Q; Zhang T; Leblanc M; Liu S; He M; Waizenegger W; Gasser E; Schnabl B; Atkins AR; Yu RT; Knight R; Liddle C; Downes M; Evans RM
Cell; 2019 Feb; 176(5):1098-1112.e18. PubMed ID: 30794774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
